New York, Aug. 31, 2020 (GLOBE NEWSWIRE) -- The global Hospital Acquired Infections (HAI) Diagnostics market is forecast to reach USD 5.68 Billion by 2027, according to a new report by Reports and Data. The market is growing due to the rise in the number of HAIs or hospital-acquired infections, and growth in the incidence of contagious virus-related diseases. The technological advancement and increasing awareness among the public have led to an increase in the number of surgical operations, which in turn is augmenting the demand in the industry.
Immediate diagnosis of infectious disease is the present need of the time due to evolving pathogens and increasing occurrence rate of hospital-acquired infections. The government of various nations has been emphasizing on rapid diagnosis of infectious disease as a strategic priority like in the U.S. The global COVID-19 pandemic is another mentionable crucial factor that is boosting the demand for laboratory-based molecular testing capacity and reagents.
However, one of the mentionable challenges for the growth of the market players amidst this epidemic is supply chain management. As an instance, in China, when the pandemic reached the zenith, transportation was brought to a halt that resulted in breaking the supply chain. The main reason for such disruption is not because companies are not manufacturing, but it was because the mobility of commodities from one part of the nation to another was becoming a challenge. Thus, such disruption in the supply chain may hinder the growth of the market.
Get FREE Sample Copy with TOC of the Report to understand the structure of the complete report@ https://www.reportsanddata.com/sample-enquiry-form/3478
The Covid-19 Impact
One of the major impacts of COVID-19 on the market has been elevated demand for point-of-care immunodiagnostic tests. The development of these easy-to-use and rapid devices to support testing outside of laboratory settings has been a response of diagnostic test manufacturers to shortage of laboratory-based molecular testing capacity. These test kits are developed based on either on detection, in serum or blood of antibodies caused due to the infection or identification of proteins from the coronavirus in respiratory samples. WHO supports the use of these point-of-care immunodiagnostic tests in research settings.
Further key findings from the report suggest
- Urinalysis testing procedure is used to detect as well as manage wide range of disorders, such as kidney diseases, urinary tract infections, and diabetes. It involves checking the concentration, appearance, and content of the urine.
- Gastrointestinal infections is among the most commonly encountered infections in primary care. They are not always severe and can often be resolved quickly. They can be of importance in inpatient populations and healthcare settings.
- Among applications, disease testing in HAI diagnostic is anticipated to witness a higher growth rate during the forecast period. Due to the advancement in technology in the healthcare sector, many modern diagnostic instruments and techniques have made the process more accurate.
- North America would hold the largest market share during the forecast period. The region is anticipated to witness several growth opportunities leading to the increase in the level of awareness among consumers owing to the presence of a large number of educational institutes, hospitals, corporate buildings, and also rise in the self-hygiene among people, which will significantly influence the growth of the industry.
- Key participants include Abbott Laboratories, Roche AG, bioMérieux, Alere, Inc., Becton Dickenson, Siemens Healthcare, Thermo Fisher Scientific, Cepheid Inc., Qiagen, and Seegene, Inc., among others.
BUY NOW (Customized Report Delivered as per Your Specific Requirement)@ https://www.reportsanddata.com/checkout-form/3478
For the purpose of this report, Reports and Data have segmented into the global Hospital Acquired Infections (HAI) Diagnostics market on the basis of the product, test type, application, infection type, end-user, and region:
Product Outlook (Revenue, USD Billion; 2017-2027)
- Consumables
- Instruments and Reagents
Test Type Outlook (Revenue, USD Billion; 2017-2027)
- Urinalysis
- Molecular Diagnostic
- Immunoassay
Application Outlook (Revenue, USD Billion; 2017-2027)
- Drug Resistance Testing
- Disease Testing
Infection Type Outlook (Revenue, USD Billion; 2017-2027)
- Bloodstream Infections
- Gastrointestinal Infections
- Hospital-Acquired Pneumonia
- Surgical Site Infections
- Urinary Tract Infections (UTI)
- Others
End Users Outlook (Revenue, USD Billion; 2017-2027)
- Clinics
- Hospitals
- Ambulatory Surgery Centers (ASC)
- Others
To identify the key trends in the industry, click on the link below: https://www.reportsanddata.com/report-detail/hospital-acquired-infections-hai-diagnostics-market
Regional Outlook (Revenue, USD Billion; 2017-2027)
- North America
- U.S
- Canada
- Europe
- Germany
- U.K
- France
- BENELUX
- Rest of Europe
- Asia Pacific
- China
- Japan
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Rest of LATAM
- MEA
- Saudi Arabia
- UAE
- Rest of MEA
Take a Look at our Related Reports:
Globally, around 3 million newborns and 1.2 million children suffer from Sepsis every year. Such high prevalence is anticipated to increase the demand for diagnostic solutions and drive Sepsis Diagnostics market growth over the forecast period.
The primary cause of the significant growth in the poultry diagnostic market is the outbreaks of poultry disease. These flock infections affect the world trade in layers, broilers, turkeys and water oats.
Blood screening is a procedure for testing the blood units to guarantee the safety of the collected blood. A rise in the prevalence of infectious disease and the rapid adoption of the latest screening technologies are fostering the demand of the market.
The market growth is likely to be driven by the prevalence of primary bloodstream infection, sepsis, kidney disorders, and other chronic infections along with associated demand for rapid diagnostic tests.
Point-of-care diagnostic also called bedside testing or near-patient testing, is a medical diagnostic test organized outside the laboratory at or at the bedside where the patient is receiving care.
An increase in the incidence of autoimmune diseases all over the world and a rise in awareness about early diagnosis will drive the market. Moreover, support from the government for faster and efficient diagnostic results will also encourage market demand.
About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client’s make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power, and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market. Reports and Data has a strong base of experienced analysts from varied areas of expertise.
Reports And Data | Web: www.reportsanddata.com
Direct Line: +1-212-710-1370
E-mail: sales@reportsanddata.com
Contact Us: John Watson Head of Business Development Reports And Data | Web: www.reportsanddata.com Direct Line: +1-212-710-1370 E-mail: sales@reportsanddata.com LinkdIn | Twitter | Blogs